ADJUVANCE TECHNOLOGIES INC. — Department of Health and Human Services SBIR Phase I: NIAID
ADJUVANCE TECHNOLOGIES INC. — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $223,002
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- NIAID
- NAICS
- —
- Place of performance
- NY
- Period
- —
Description
The Contractor will develop TiterQuil a semi synthetic saponin adjuvant analog of QS for the purpose of improving the immunogenicity of commercially available flu vaccines Fluzone Sanofi Pasteur Fluvirin Seqirus and Flublok Protein Sciences